Gold tier: mechanically validated evidence, with its primary source.
1,197 evidence items · page 22 / 48
16 %The 3D7 MSP-1(19) haplotype had an overall prevalence of 16% in malaria infections among 100 children in Mali from 1999 to 2001.
Malipaludismeobserved 1999 to 2001published 2007PLoS medicineeurope_pmcdocument of 5 observationsDOI 10.1371/journal.pmed.0040093
0.32 %La prévalence de Plasmodium ovale était de 0,32 % lors du dépistage passif dans la commune rurale de Ntjiba, Mali, entre 2016 et 2021.
Malipaludismeobserved 2016 à 2021HAL · Unilimdocument of 214 observations
3 allelesImmunization with the malaria vaccine was followed by significant increases in antibodies recognizing three diverse MSP-1(42) alleles and their subunits.
Malipaludismepublished 2006PLoS clinical trialseurope_pmcdocument of 2 observations
22.1 %The overall estimated prevalence of positive Leishmanin Skin Test was 22.1%.
Malicutaneous leishmaniasispublished 2016Asian Pacific journal of tropical medicineeurope_pmcdocument of 3 observations
5 %La prévalence du paludisme clinique a atteint 5 % durant les années considérées dans l'étude à Kati Faladié.
MalipaludismeHAL · Unilimdocument of 214 observations
Les infections par des espèces autres que P. falciparum ainsi que les infections mixtes par P. falciparum étaient presque toujours associées à des parasitémies modérées à faibles.
MalipaludismeHAL · Unilimdocument of 214 observations
84.2 %Plasmodium falciparum accounted for 84.2% of malaria infections in children aged less than 15 years in Dabbis sub-prefecture, Boke region, Guinea.
Malipaludismeobserved 2017published 2021The Journal of parasitologyeurope_pmcdocument of 7 observations
385 deathsAs of 31 March 2021, there were 385 deaths from COVID-19 reported in Mali.
MaliCOVID-19observed 31 March 2021HAL · Unilimdocument of 8 observations
90 %Plasmodium falciparum représentait 90 % des cas de paludisme au Mali.
MalipaludismeHAL · Unilimdocument of 214 observations
71.1 %Among 266 COVID-19 donor samples, 189 (71.1%) recognized the RBD protein.
MaliCOVID-19HAL · Unilimdocument of 67 observations
10 %In Mali, chloroquine treatment for uncomplicated P. falciparum malaria showed 10–15% treatment failure rates.
Malipaludismepublished 2001The American journal of tropical medicine and hygieneeurope_pmcdocument of 3 observationsDOI 10.4269/ajtmh.2001.64.242
2.2 %Annual referral rates of severe cases, regardless of SpO2 level, were 2.2% in Mali before the introduction of pulse oximetry.
Malisevere casesobserved 2019HAL · Unilimdocument of 229 observations
1.4 %The HIV prevalence rate is 1.4% in Mali.
MaliVIH/sidaHAL · Unilimdocument of 97 observations
71.1 %Among 266 COVID-19 samples, 189 (71.1%) recognized the receptor-binding domain (RBD) antigen.
MaliCOVID-19HAL · Unilimdocument of 67 observations
11 %The pfmdr1 86Y population prevalence decreased from 11.0% at baseline to 0% in patients with recurrent infection.
Malipaludismeobserved 2009published 2021International journal of molecular scienceseurope_pmcdocument of 4 observationsDOI 10.3390/ijms22116057
83.5 %In Mali, a retrospective study conducted at CHU Gabriel Touré in Bamako between 2014 and 2018 showed a reduction in cerebral malaria frequency to 83.5% after SMC introduction.
Malipaludismeobserved 2014–2018HAL · Unilimdocument of 147 observations
5.88 %The prevalence rate of Plasmodium malariae was 5.88% in the Fulani population.
Malipaludismepublished 2017PloS oneeurope_pmcdocument of 14 observationsDOI 10.1371/journal.pone.0189724
64.8 %In Greater Bamako, 64.8% of confirmed COVID-19 cases in Mali were recorded.
MaliCOVID-19HAL · Unilimdocument of 88 observations
59.33 %La prévalence des monoinfections à Plasmodium falciparum chez les individus symptomatiques était de 59,33 %.
MalipaludismeHAL · Unilimdocument of 214 observations
99.64 %HemotypeSC® had a negative predictive value of 99.64% to detect sickle cell disease compared to high-performance liquid chromatography.
MalidrépanocytoseHAL · Unilimdocument of 103 observations
4,000,000 deathsOver 4 million deaths have been reported worldwide for COVID-19.
MaliCOVID-19HAL · Unilimdocument of 67 observations
-61.77 millisecondsPatients with uncomplicated falciparum malaria had shorter QT intervals by -61.77 milliseconds compared to healthy participants.
Malipaludismepublished 2020PLoS medicineeurope_pmcdocument of 6 observationsDOI 10.1371/journal.pmed.1003040
51 %In children who received RTS,S/AS01E vaccine in Burkina Faso and Mali, 51% showed a 10-fold increase in anti-CSP IgG antibody titres post-2018 as measured by Oxford MSD assay.
Burkina Faso · Malipaludismeobserved post-2018HAL · Unilimdocument of 105 observations
57 Health Districts57 Health Districts in Mali were identified for seasonal malaria chemoprevention (SMC).
MalipaludismeHAL · Unilimdocument of 95 observations
Infection rates for P. malariae varied between age-groups, with the highest rates in individuals aged > 5 years.
Malipaludismeobserved 2017, 2018published 2020The American journal of tropical medicine and hygieneeurope_pmcdocument of 6 observationsDOI 10.4269/ajtmh.20-0593
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.